First blood test for Alzheimer's gets FDA greenlight: 3 things to know
Medical News Today,
Share on PinterestThe FDA has cleared the first blood test to diagnose Alzheimer’s disease.
The Interplay Between Beta-Amyloid 1–42 (Aβ1–42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
Overview of attention for article published in Frontiers in Molecular Neuroscience, November 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Readers on
- mendeley
- 68 Mendeley
